Substance Name: Atezolizumab [USAN:INN]
RN: 1380723-44-3
UNII: 52CMI0WC3Y
Note
- A monoclonal antibody that targets programmed death-ligand 1 (CD274 ANTIGEN) and is used to treat urothelial carcinoma, the most common type of bladder cancer.
Molecular Formula
- C6446-H9902-N1706-O1998-S42
Classification Codes
- Antineoplastic Agents
- Treatment of Solid Tumors
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
- PubChem
- PubMed
- PubMed*
- PubMed AIDS
- PubMed Cancer
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Atezolizumab
- Atezolizumab [USAN:INN]
Synonyms
- anti-PD-L1 monoclonal antibody MPDL3280A
- Atezolizumab
- Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer
- MPDL 3280A
- MPDL-3280A
- MPDL3280A
- RG 7446
- Tecentriq
- UNII-52CMI0WC3Y
Registry Numbers
CAS Registry Number
- 1380723-44-3
FDA UNII
- 52CMI0WC3Y
Other Registry Number
- 1422185-06-5
System Generated Number
- 1380723443